These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
538 related items for PubMed ID: 21701419
1. Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Walker J, Dichter E, Lacorte G, Kerner D, Spur B, Rodriguez A, Yin K. Shock; 2011 Oct; 36(4):410-6. PubMed ID: 21701419 [Abstract] [Full Text] [Related]
2. Lipoxin A(4) promotes more complete inflammation resolution in sepsis compared to stable lipoxin A(4) analog. Wu B, Walker JA, Temmermand D, Mian K, Spur B, Rodriguez A, Stein TP, Banerjee P, Yin K. Prostaglandins Leukot Essent Fatty Acids; 2013 Jul; 89(1):47-53. PubMed ID: 23688707 [Abstract] [Full Text] [Related]
3. Effects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis. Wu B, Walker J, Spur B, Rodriguez A, Yin K. Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():55-64. PubMed ID: 25476955 [Abstract] [Full Text] [Related]
4. The protective effects of Lipoxin A4 during the early phase of severe acute pancreatitis in rats. Zhou M, Chen B, Sun H, Deng Z, Andersson R, Zhang Q. Scand J Gastroenterol; 2011 Feb; 46(2):211-9. PubMed ID: 20950211 [Abstract] [Full Text] [Related]
5. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLP-induced sepsis in rats. Feng X, Yan W, Liu X, Duan M, Zhang X, Xu J. J Surg Res; 2006 Sep; 135(1):129-36. PubMed ID: 16616763 [Abstract] [Full Text] [Related]
6. Dual role of lipoxin A4 in pneumosepsis pathogenesis. Sordi R, Menezes-de-Lima O, Horewicz V, Scheschowitsch K, Santos LF, Assreuy J. Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538 [Abstract] [Full Text] [Related]
7. Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition. Wu B, Capilato J, Pham MP, Walker J, Spur B, Rodriguez A, Perez LJ, Yin K. FASEB J; 2016 Jun; 30(6):2400-10. PubMed ID: 26965685 [Abstract] [Full Text] [Related]
8. Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-alpha levels, MDA content and enhancing macrophage phagocytosis. Ma H, Kou J, Zhu D, Yan Y, Yu B. Int Immunopharmacol; 2006 Aug; 6(8):1355-62. PubMed ID: 16782549 [Abstract] [Full Text] [Related]
9. Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury. Lv W, Lv C, Yu S, Yang Y, Kong H, Xie J, Sun H, Andersson R, Xu D, Chen B, Zhou M. Exp Biol Med (Maywood); 2013 Dec; 238(12):1388-95. PubMed ID: 24000382 [Abstract] [Full Text] [Related]
10. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*. Ueda T, Fukunaga K, Seki H, Miyata J, Arita M, Miyasho T, Obata T, Asano K, Betsuyaku T, Takeda J. Crit Care Med; 2014 Apr; 42(4):e288-95. PubMed ID: 24463858 [Abstract] [Full Text] [Related]
11. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kutsumi H, Arita M, Azuma T, Yoshida M. J Pharmacol Exp Ther; 2010 Feb; 332(2):541-8. PubMed ID: 19846590 [Abstract] [Full Text] [Related]
12. The lipoxin A4 agonist BML-111 attenuates acute hepatic dysfunction induced by cecal ligation and puncture in rats. El-Tanbouly GS, El-Awady MS, Megahed NA, El-Kashef HA, Salem HA. Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):361-368. PubMed ID: 28035464 [Abstract] [Full Text] [Related]
13. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Sheehan M, Wong HR, Hake PW, Zingarelli B. Crit Care Med; 2003 Sep; 31(9):2263-70. PubMed ID: 14501955 [Abstract] [Full Text] [Related]
14. Lipoxin A4 attenuates adipose inflammation. Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C. FASEB J; 2012 Oct; 26(10):4287-94. PubMed ID: 22700871 [Abstract] [Full Text] [Related]
15. [Protective effects of 15-methyl-lipoxin A4 on mesangioproliferative nephritis in rats]. Wu SH, Liao PY, Dong L, Jiang XY. Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):225-30. PubMed ID: 16787597 [Abstract] [Full Text] [Related]
16. Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway. Jiang X, Li Z, Jiang S, Tong X, Zou X, Wang W, Zhang Z, Wu L, Tian D. Int J Mol Med; 2016 Mar; 37(3):773-80. PubMed ID: 26865215 [Abstract] [Full Text] [Related]
17. Lipoxin A4 Restores Septic Renal Function via Blocking Crosstalk Between Inflammation and Premature Senescence. Chen C, Qiu R, Yang J, Zhang Q, Sun G, Gao X, Hei Z, Ji H. Front Immunol; 2021 Mar; 12():637753. PubMed ID: 33936050 [Abstract] [Full Text] [Related]
18. Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis. Yu M, Shao D, Liu J, Zhu J, Zhang Z, Xu J. Int Immunopharmacol; 2007 Aug; 7(8):1076-82. PubMed ID: 17570324 [Abstract] [Full Text] [Related]
19. Protocatechuic aldehyde protects against experimental sepsis in vitro and in vivo. Xu Y, Jiang WL, Zhang SP, Zhu HB, Hou J. Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):384-9. PubMed ID: 22050905 [Abstract] [Full Text] [Related]
20. Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsis. Feng X, Liu J, Yu M, Zhu S, Xu J. Clin Chim Acta; 2007 Feb; 376(1-2):60-7. PubMed ID: 16942763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]